El método AMFE (Análisis Modal de Fallos y Efectos) aplicado a la anticoagulación de pacientes con fibrilación auricular no valvular

  1. F. Atienza-Martín 1
  2. V. Barrios 2
  3. M.I. Egocheaga 3
  4. R. Hidalgo 5
  5. N. Marín-Montañés 4
  6. C. Ramis 6
  1. 1 Unidad de Gestión Clínica M.ª Fuensanta Pérez Quirós, Distrito Sanitario Sevilla, Sevilla, España
  2. 2 Servicio de Cardiología, Hospital Universitario Ramón y Cajal, Madrid, España
  3. 3 Centro de Salud Isla de Oza, Distrito Sanitario Moncloa-Fuencarral, Madrid, España
  4. 4 Bayer España, Sant Joan Despí, Barcelona, España
  5. 5 Unidad de Gestión Clínica de Cardiología y Cirugía Cardiovascular, Hospital Universitario Virgen de Macarena, Sevilla, España
  6. 6 GOC Networking, Barcelona, España
Show affiliations +
Journal:
Semergen: revista española de medicina de familia

ISSN: 1138-3593

Year of publication: 2019

Issue: 3

Pages: 169-179

Type: Article

DOI: 10.1016/J.SEMERG.2018.04.011 DIALNET GOOGLE SCHOLAR

More publications in: Semergen: revista española de medicina de familia

Abstract

Objectives To contribute to the improvement of the process of anticoagulation in patients with nonvalvular atrial fibrillation (NVAF) through awareness and training activities for Primary Care Physicians. Materials and methods A total of 38 focus groups, sequenced according to an adaptation of the Failure Mode and Effects Analysis (FMEA) method. Each meeting was driven by «brainstorming» methodology. The geographical representation was homogeneous, with a total of 482 national. physicians (444 Primary Care Physicians, and 38 cardiologists). The meetings were held between March 28 and June 20, 2017. Results The main unsafe actions that can lead to a haemorrhagic or thrombotic event are incorrect anticoagulation or lack of patient follow-up. These events are mainly caused by training deficiencies in the management of NVAF, or by not taking into account possible interactions with vitamin K antagonist drugs. The main recommendations to alleviate these failures were focused on a good follow-up of patients with NVAF, on creating or updating the protocols or clinical practice guidelines, and on promoting the continuous training of physicians who usually manage patients with non-valvular AF treated with oral anticoagulants. Conclusions A significant percentage of patients with NVAF are not correctly anticoagulated. Specific actions are required to alleviate this problem. Among them, the importance of a general anticoagulation training was emphasised, and particularly, the use of direct oral anticoagulants.

€ View funding

Funding information

Los autores manifiestan su agradecimiento a todos los participantes de las sesiones de trabajo, a la empresa GOC Networking por su apoyo metodol?gico a lo largo de todo el proceso y a Laboratorios Bayer.

Funders

Bibliographic References

  • J. Perez-Villacastin, N. Perez Castellano, J. Moreno Planas Epidemiology of atrial fibrillation in Spain in the past 20 years Rev Esp Cardiol (Engl Ed), 66 (2013), pp. 561-565 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • M. Proietti, A.M. Marra, E.J. Tassone, S. de Vuono, S. Corrao, P. Gobbi, et al. Frequency of left ventricular hypertrophy in non-valvular atrial fibrillation Am J Cardiol, 116 (2015), pp. 877-882 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • Ministerio de Sanidad y Política Social. Estrategia en Ictus del Sistema Nacional de Salud. Madrid: Ministerio de Sanidad y Política Social; 2009 [consultado 1 Dic 2018]. Disponible en http://www.mscbs.gob.es/organizacion/sns/planCalidadSNS/docs/EstrategiaIctusSNS.pdf Google Scholar
  • Evaluación de la Estrategia en Ictus del Sistema Nacional de Salud. 2013 [consultado 28 Nov 2017]; Disponible en: http://saludcantabria.es/uploads/pdf/noticias/Punto%2011-%20Evaluacion%20Estrategia%20en%20Ictus%20del%20SNS%202013.pdf. Google Scholar
  • J.J. Gomez-Doblas, J. Muniz, J.J. Martin, G. Rodriguez-Roca, J.M. Lobos, P. Awamleh, et al. Prevalence of atrial fibrillation in Spain OFRECE study results Rev Esp Cardiol (Engl Ed), 67 (2014), pp. 259-269 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • J.M. Baena-Diez, M. Grau, R. Fores, D. Fernandez-Berges, R. Elosua, M. Sorribes, et al. Prevalence of atrial fibrillation and its associated factors in Spain: An analysis of 6 population-based studies DARIOS Study Rev Clin Esp, 214 (2014), pp. 505-512 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • A. Massó-van Roessel, L.A. Escobar-Robledo, I.R. Dégano, M. Grau, J. Sala, R. Ramos, et al. Analysis of the Association Between Electrocardiographic P-wave Characteristics and Atrial Fibrillation in the REGICOR Study Rev Esp Cardiol (Engl Ed), 70 (2017), pp. 841-847 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • V. Barrios, A. Calderón, C. Escobar, M. de la Figuera Primary Care Group in the Clinical Cardiology Section of the Spanish Society of Cardiology Pacientes con fibrilación auricular asistidos en consultas de atención primaria. Estudio Val-FAAP Rev Esp Cardiol., 65 (2012), pp. 47-53 2012;65:47-53 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • M. Haim, M. Hoshen, O. Reges, Y. Rabi, R. Balicer, M. Leibowitz Prospective National Study of the Prevalence, Incidence Management and Outcome of a Large Contemporary Cohort of Patients With Incident Non Valvular Atrial Fibrillation In: J Am Heart Assoc; (2015) Google Scholar
  • M.A. Khan, S. Raja, M.S. Ibrahim, C. Hammersely Prevalence and management of atrial fibrillation in primary care: a case study Prim Health Care Res Dev, 15 (2014), pp. 355-361 CrossRefView Record in ScopusGoogle Scholar
  • P. Kirchhof, S. Benussi, D. Kotecha, A. Ahlsson, D. Atar, B. Casadei, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS Eur Heart J, 37 (2016), pp. 2893-2962 CrossRefView Record in ScopusGoogle Scholar
  • C.T. Ruff, R.P. Giugliano, E. Braunwald, E.B. Hoffman, N. Deenadayalu, M.D. Ezekowitz, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials Lancet, 383 (2014), pp. 955-962 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • NICE Guidance: Non-vitamin K antagonist oral anticoagulants (NOACs) Key therapeutic. topic Published: 26 February 2016. p. 4 [consultado 1 Dic 2018]. Disponible en: https://www.nice.org.uk/advice/ktt16/resources/anticoagulants-including-nonvitamin-k-antagonist-oral-anticoagulants-noacs-pdf-58757956094149 Google Scholar
  • Agencia Española de Medicamentos y Productos Sanitarios. Ministerio de Sanidad Servicios Sociales e Igualdad. Informe de posicionamiento terapéutico UT ACOD/V5/21112016. Criterios y recomendaciones generales para el uso de los anticoagulantes orales directos (ACOD) en la prevención del ictus y la embolia sistémica en pacientes con fibrilación auricular no valvular. Fecha de publicación: 21 de noviembre de 2016 [consultado 1 Dic 2018]. Disponible en https://www.aemps.gob.es/medicamentosUsoHumano/informesPublicos/docs/criterios-anticoagulantes-orales.pdf Google Scholar
  • V. Barrios, C. Escobar [From clinical trials to clinical practice Experience with rivaroxaban in the anticoagulant treatment of patients with non-valvular atrial fibrillation] Semergen, 43 (2017), pp. 222-229 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • V. Barrios, C. Escobar, L. Prieto, G. Osorio, J. Polo, J.M. Lobos, et al. Anticoagulation control in patients with nonvalvular atrial fibrillation attended at Primary Care Centers in Spain: The PAULA Study Rev Esp Cardiol (Engl Ed), 68 (2015), pp. 769-776 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • J. Polo Garcia, V. Barrios Alonso, C. Escobar Cervantes, L. Prieto Valiente, J.M. Lobos Bejarano, D. Vargas Ortega, et al. Control de la anticoagulación en pacientes con fibrilación auricular no valvular en práctica clínica de atención primaria en las diferentes comunidades autónomas Estudio PAULA Semergen, 43 (2017), pp. 207-215 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • M. Anguita Sanchez, V. Bertomeu Martinez, A. Cequier Fillat Quality of Vitamin K Antagonist Anticoagulation in Spain: Prevalence of Poor Control and Associated Factors Rev Esp Cardiol (Engl Ed), 68 (2015), pp. 761-768 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • S. Cinza-Sanjurjo, D. Rey-Aldana, E. Gestal-Pereira, C. Calvo-Gomez Assessment of degree of anticoagulation control in patients with atrial fibrillation in Primary Health Care in Galicia Spain: ANFAGAL Study Rev Esp Cardiol (Engl Ed), 68 (2015), pp. 753-760 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • V. Barrios, C. Escobar, J.M. Lobos, J. Polo, D. Vargas Uso de los anticoagulantes orales de acción directa en atención primaria: Estudio ACTUA Semergen, 43 (2017), pp. 477-485 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • E.M. Hylek, A.S. Go, Y. Chang, N.G. Jensvold, L.E. Henault, J.V. Selby, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation N Engl J Med, 349 (2003), pp. 1019-1026 View Record in ScopusGoogle Scholar
  • C.L. Morgan, P. McEwan, A. Tukiendorf, P.A. Robinson, A. Clemens, J.M. Plumb Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control Thromb Res, 124 (2009), pp. 37-41 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • J. Lopez-Sendon, J.L. Merino Poor anticoagulation control in atrial fibrillation: how much longer? Rev Esp Cardiol (Engl Ed), 68 (2015), pp. 740-742 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • AMFE: Análisis Modal de Fallos y Efectos – Guía y ejemplos de uso| PDCA Home. 2017 [consultado 23 Oct 2017]. Disponible en: https://www.pdcahome.com/3891/amfe-guia-de-uso-del-analisis-modal-de-fallos-y-efectos/. Google Scholar
  • Ministerio de Trabajo y Asuntos Sociales: Instituto Nacional de Seguridad e Higiene en el Trabajo. NTP 679: Análisis modal de fallos y efectos. AMFE. Fecha de publicación: 2004 [consultado 1 Dic 2018]. Disponible en: http://www.insht.es/InshtWeb/Contenidos/Documentacion/FichasTecnicas/NTP/Ficheros/601a700/ntp_679.pdf Google Scholar
  • Atienza FJ. Análisis Modal de Fallos y Efectos (AMFE). Aplicación a la seguridad en el ámbito de la Atención Primaria. Itinerario para la Seguridad del Paciente An Atención Primaria (SPIF-AP). Curso virtual de la EASP. ISBN 978-84-608-5116-5. Google Scholar
  • F. Alba Mesa, M.A. Sanchez Hurtado, F.M. Sanchez Margallo, V. Gomez Cabeza de Vaca, A.L. Komorowski Application of failure mode and effect analysis in laparoscopic colon surgery training World J Surg, 39 (2015), pp. 536-542 CrossRefView Record in ScopusGoogle Scholar
  • A. Vazquez-Valencia, A. Santiago-Saez, B. Perea-Perez, E. Labajo-Gonzalez, M.E. Albarran-Juan Utility of failure mode and effect analysis to improve safety in suctioning by orotracheal tube J Perianesth Nurs, 32 (2017), pp. 28-37 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • M.D. Arenas Jimenez, G. Ferre, F. Alvarez-Ude Strategies to increase patient safety in Hemodialysis: Application of the modal analysis system of errors and effects (FEMA system) Nefrologia, 37 (2017), pp. 608-621 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • Astier Peña MP, Maderuelo Fernández JÁ, Jiménez Julvez MT, Martín Rodríguez MD, Palacio Lapuente J, Oliveras Cañada G. Análisis proactivo del riesgo: el análisis modal de fallos y efectos (AMFE). Revista clínica electrónica en atención primaria 2010:0001-0008. Google Scholar
  • Sociedad Española de Cardiología. SEC-PRIMARIA. 2017 [consultado 11 Dic 2017]. Disponible en: https://secardiologia.es/institucional/reuniones-institucionales/sec-calidad/sec-primaria. Google Scholar
Data source: Dialnet